Global Biodefense Market By Product - Industry Analysis And Forecast To 2027

Published On : September 2018 Pages : 135 Category: Defence & Security Report Code : DEF091332

SEGMENTS & REGIONS:

Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Report Description
Table of Content

Biodefense Market By Product (Radiation/ Nuclear Defense, Anthrax, Botulism, Smallpox And Other Products) - Global Industry Analysis And Forecast To 2027

Industry Outlook

Biological attack is the intentional attack by viruses, bacteria and other germs that cause death or severe illness. These germs are present in the environment but their power is increased by to make the more harmful. These biological agents spread through ways like water, air or food. Biodefense makes use of medical measures to protecting the population against the biological attack. This includes steps like preparation & research and also vaccinations & medications against biological attack. Biodefense is the terms that mainly deals with bio-war or bioterrorism and includes the military or emergency response. The Biodefense mechanism is growing due to factors like; rising R&D related to the field, rising investment by various governments across the world for protecting people, technical advancement in various initiatives, etc. Therefore, the Biodefense Market is anticipated to expand and has tremendous scope during the forecast period. The global Biodefense Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Biodefense Market is based on segment, by Product the market is segmented into Radiation/ Nuclear Defense, Anthrax, Botulism, Smallpox and Other Products. .

Biodefense Market, By Product

Radiation/ Nuclear Defense
Anthrax
Botulism
Smallpox
Other Products

Regional Insights

On a global front, the Biodefense Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is dominating the Biodefense Market owing to higher number of government initiatives.

Biodefense Market, By Region

- North America
U.S.
Canada
Mexico
- Europe
Germany
UK
France
Russia
Italy
Rest of Europe
- Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
- South America
Brazil
Argentina
Columbia
Rest of South America
- Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA

Competitive Analysis

The leading players in the market are Alnylam Pharmaceuticals Inc., Ichor Medical Systems, Xoma Corporation, Nanotherapeutics Inc., PharmAthene Inc., Achaogen Inc., Emergent BioSolutions Inc., Bavarian Nordic, Dynavax Technologies Corporation, Cleveland BioLabs, SIGA Technologies, DynPort Vaccine Company LLC and Elusys Therapeutics Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

Alnylam Pharmaceuticals Inc.
Ichor Medical Systems
Xoma Corporation
Nanotherapeutics Inc.
PharmAthene Inc.
Achaogen Inc.
Emergent BioSolutions Inc.
Bavarian Nordic
Dynavax Technologies Corporation
Cleveland BioLabs
SIGA Technologies
DynPort Vaccine Company LLC
Elusys Therapeutics Inc.

Some of the key questions answered by the report are:

What was the market size in 2017 and forecast from 2017 to 2027?
What will be the industry market growth from 2017 to 2027?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

o Biodefense Market, By Product, Estimates and Forecast, 2017-2027 ($Million)

o Radiation/ Nuclear Defense

o Anthrax

o Botulism

o Smallpox

o Other Products

o Biodefense Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o North America

§ North America Biodefense Market, By Country

o U.S. Biodefense Market

o Canada Biodefense Market

o Mexico Biodefense Market

o Europe

§ Europe Biodefense Market, By Country

o Germany Biodefense Market

o UK Biodefense Market

o France Biodefense Market

o Russia Biodefense Market

o Italy Biodefense Market

o Rest of Europe Biodefense Market

o Asia-Pacific

§ Asia-Pacific Biodefense Market, By Country

o China Biodefense Market

o Japan Biodefense Market

o South Korea Biodefense Market

o India Biodefense Market

o Southeast Asia Biodefense Market

o Rest of Asia-Pacific Biodefense Market

o South America

§ South America Biodefense Market, By Country

o Brazil Biodefense Market

o Argentina Biodefense Market

o Columbia Biodefense Market

o Rest of South America Biodefense Market

o Middle East and Africa

§ Middle East and Africa Biodefense Market, By Country

o Saudi Arabia Biodefense Market

o UAE Biodefense Market

o Egypt Biodefense Market

o Nigeria Biodefense Market

o South Africa Biodefense Market

o Rest of MEA Biodefense Market

Table of Contents

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. SWOT Analysis

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market Status and Outlook (2017-2027)

4.1.2. Canada Market Status and Outlook (2017-2027)

4.1.3. Mexico Market Status and Outlook (2017-2027)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market Status and Outlook (2017-2027)

4.2.2. France Market Status and Outlook (2017-2027)

4.2.3. UK Market Status and Outlook (2017-2027)

4.2.4. Russia Market Status and Outlook (2017-2027)

4.2.5. Italy Market Status and Outlook (2017-2027)

4.2.6. Rest of Europe Market Status and Outlook (2017-2027)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market Status and Outlook (2017-2027)

4.3.2. Japan Market Status and Outlook (2017-2027)

4.3.3. Korea Market Status and Outlook (2017-2027)

4.3.4. India Market Status and Outlook (2017-2027)

4.3.5. Southeast Asia Market Status and Outlook (2017-2027)

4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market Status and Outlook (2017-2027)

4.4.2. Argentina Market Status and Outlook (2017-2027)

4.4.3. Columbia Market Status and Outlook (2017-2027)

4.4.4. Rest of South America Market Status and Outlook (2017-2027)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3. Egypt Market Status and Outlook (2017-2027)

4.5.4. Nigeria Market Status and Outlook (2017-2027)

4.5.5. South Africa Market Status and Outlook (2017-2027)

4.5.6. Turkey Market Status and Outlook (2017-2027)

4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5. Biodefense Market, By Product

5.1. Introduction

5.2. Global Biodefense Revenue and Market Share by Product (2017-2027)

5.2.1. Global Biodefense Revenue and Revenue Share by Product (2017-2027)

5.3. Radiation/ Nuclear Defense

5.3.1. Global Radiation/ Nuclear Defense Revenue and Growth Rate (2017-2027)

5.4. Anthrax

5.4.1. Global Anthrax Revenue and Growth Rate (2017-2027)

5.5. Botulism

5.5.1. Global Botulism Revenue and Growth Rate (2017-2027)

5.6. Smallpox

5.6.1. Global Smallpox Revenue and Growth Rate (2017-2027)

5.7. Other Products

5.7.1. Global Other Products Revenue and Growth Rate (2017-2027)

6. Biodefense Market, By Region

6.1. Introduction

6.2. Global Biodefense Revenue and Market Share by Regions

6.2.1. Global Biodefense Revenue by Regions (2017-2027)

6.3. North America Biodefense by Countries

6.3.1. North America Biodefense Revenue and Growth Rate (2017-2027)

6.3.2. North America Biodefense Revenue (Million USD) by Countries (2017-2027)

6.3.3. United States

6.3.3.1. United States Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.4. Canada

6.3.4.1. Canada Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.5. Mexico

6.3.5.1. Mexico Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.4. Europe Biodefense by Countries

6.4.1. Europe Biodefense Revenue and Growth Rate (2017-2027)

6.4.2. Europe Biodefense Revenue (Million USD) by Countries (2017-2027)

6.4.3. Germany

6.4.3.1. Germany Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.4. France

6.4.4.1. France Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.5. UK

6.4.5.1. UK Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6. Russia

6.4.6.1. Russia Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7. Italy

6.4.7.1. Italy Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8. Rest of Europe

6.4.8.1. Rest of Europe Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.5. Asia-Pacific Biodefense by Countries

6.5.1. Asia-Pacific Biodefense Revenue and Growth Rate (2017-2027)

6.5.2. Asia-Pacific Biodefense Revenue (Million USD) by Countries (2017-2027)

6.5.3. China

6.5.3.1. China Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.4. Japan

6.5.4.1. Japan Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5. Korea

6.5.5.1. Korea Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.6. India

6.5.6.1. India Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7. Southeast Asia

6.5.7.1. Southeast Asia Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8. Rest of Asia-Pacific

6.5.8.1. Rest of Asia-Pacific Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.6. South America Biodefense by Countries

6.6.1. South America Biodefense Revenue and Growth Rate (2017-2027)

6.6.2. South America Biodefense Revenue (Million USD) by Countries (2017-2027)

6.6.3. Brazil

6.6.3.1. Brazil Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.4. Argentina

6.6.4.1. Argentina Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.5. Columbia

6.6.5.1. Columbia Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6. Rest of South America

6.6.6.1. Rest of South America Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.7. Middle East and Africa Biodefense by Countries

6.7.1. Middle East and Africa Biodefense Revenue and Growth Rate (2017-2027)

6.7.2. Middle East and Africa Biodefense Revenue (Million USD) by Countries (2017-2027)

6.7.3. Saudi Arabia

6.7.3.1. Saudi Arabia Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.4. United Arab Emirates

6.7.4.1. United Arab Emirates Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.5. Egypt

6.7.5.1. Egypt Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6. Nigeria

6.7.6.1. Nigeria Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7. South Africa

6.7.7.1. South Africa Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8. Turkey

6.7.8.1. Turkey Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9. Rest of Middle East and Africa

6.7.9.1. Rest of Middle East and Africa Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

7. Company Profiles

7.1. Alnylam Pharmaceuticals Inc.

7.1.1. Business Overview

7.1.2. Service Portfolio

7.1.3. Strategic Developments

7.1.4. Revenue and Market Share

7.2. Ichor Medical Systems

7.2.1. Business Overview

7.2.2. Service Portfolio

7.2.3. Strategic Developments

7.2.4. Revenue and Market Share

7.3. Xoma Corporation

7.3.1. Business Overview

7.3.2. Service Portfolio

7.3.3. Strategic Developments

7.3.4. Revenue and Market Share

7.4. Nanotherapeutics Inc.

7.4.1. Business Overview

7.4.2. Service Portfolio

7.4.3. Strategic Developments

7.4.4. Revenue and Market Share

7.5. PharmAthene Inc.

7.5.1. Business Overview

7.5.2. Service Portfolio

7.5.3. Strategic Developments

7.5.4. Revenue and Market Share

7.6. Achaogen Inc.

7.6.1. Business Overview

7.6.2. Service Portfolio

7.6.3. Strategic Developments

7.6.4. Revenue and Market Share

7.7. Emergent BioSolutions Inc.

7.7.1. Business Overview

7.7.2. Service Portfolio

7.7.3. Strategic Developments

7.7.4. Revenue and Market Share

7.8. Bavarian Nordic

7.8.1. Business Overview

7.8.2. Service Portfolio

7.8.3. Strategic Developments

7.8.4. Revenue and Market Share

7.9. Dynavax Technologies Corporation

7.9.1. Business Overview

7.9.2. Service Portfolio

7.9.3. Strategic Developments

7.9.4. Revenue and Market Share

7.10. Cleveland BioLabs

7.10.1. Business Overview

7.10.2. Service Portfolio

7.10.3. Strategic Developments

7.10.4. Revenue and Market Share

7.11. SIGA Technologies

7.11.1. Business Overview

7.11.2. Service Portfolio

7.11.3. Strategic Developments

7.11.4. Revenue and Market Share

7.12. DynPort Vaccine Company LLC

7.12.1. Business Overview

7.12.2. Service Portfolio

7.12.3. Strategic Developments

7.12.4. Revenue and Market Share

7.13. Elusys Therapeutics Inc.

7.13.1. Business Overview

7.13.2. Service Portfolio

7.13.3. Strategic Developments

7.13.4. Revenue and Market Share

8. Global Biodefense Market Competition, by Manufacturer

8.1. Global Biodefense Revenue and Market Share by Manufacturer (2017-2017)

8.2. Global Biodefense Price By Region (2017-2017)

8.3. Top 5 Biodefense Manufacturer Market Share

8.4. Market Competition Trend

9. Biodefense Market Forecast (2017-2027)

9.1. Global Biodefense Revenue (Millions USD) and Growth Rate (2017-2027)

9.2. Biodefense Market Forecast by Regions (2017-2027)

9.2.1. North America Biodefense Market Forecast (2017-2027)

9.2.1.1. United States Biodefense Market Forecast (2017-2027)

9.2.1.2. Canada Biodefense Market Forecast (2017-2027)

9.2.1.3. Mexico Biodefense Market Forecast (2017-2027)

9.2.2. Europe Biodefense Market Forecast (2017-2027)

9.2.2.1. Germany Biodefense Market Forecast (2017-2027)

9.2.2.2. France Biodefense Market Forecast (2017-2027)

9.2.2.3. UK Biodefense Market Forecast (2017-2027)

9.2.2.4. Russia Biodefense Market Forecast (2017-2027)

9.2.2.5. Italy Biodefense Market Forecast (2017-2027)

9.2.2.6. Rest of Europe Biodefense Market Forecast (2017-2027)

9.2.3. Asia-Pacific Biodefense Market Forecast (2017-2027)

9.2.3.1. China Biodefense Market Forecast (2017-2027)

9.2.3.2. Japan Biodefense Market Forecast (2017-2027)

9.2.3.3. Korea Biodefense Market Forecast (2017-2027)

9.2.3.4. India Biodefense Market Forecast (2017-2027)

9.2.3.5. Southeast Asia Biodefense Market Forecast (2017-2027)

9.2.3.6. Rest of Asia-Pacific Biodefense Market Forecast (2017-2027)

9.2.4. South America Biodefense Market Forecast (2017-2027)

9.2.4.1. Brazil Biodefense Market Forecast (2017-2027)

9.2.4.2. Argentina Biodefense Market Forecast (2017-2027)

9.2.4.3. Columbia Biodefense Market Forecast (2017-2027)

9.2.4.4. Rest of South America Biodefense Market Forecast (2017-2027)

9.2.5. Middle East and Africa Biodefense Market Forecast (2017-2027)

9.2.5.1. Saudi Arabia Biodefense Market Forecast (2017-2027)

9.2.5.2. United Arab Emirates Biodefense Market Forecast (2017-2027)

9.2.5.3. Egypt Biodefense Market Forecast (2017-2027)

9.2.5.4. Nigeria Biodefense Market Forecast (2017-2027)

9.2.5.5. South Africa Biodefense Market Forecast (2017-2027)

9.2.5.6. Turkey Biodefense Market Forecast (2017-2027)

9.2.5.7. Rest of Middle East and Africa Biodefense Market Forecast (2017-2027)

9.3. Biodefense Market Forecast by Product (2017-2027)

9.3.1. Biodefense Forecast by Product (2017-2027)

9.3.2. Biodefense Market Share Forecast by Product (2017-2027)

List of Tables

10. List of Tables and Figures

Figure United States Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Canada Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Mexico Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Germany Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure France Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure UK Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Russia Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Italy Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Europe Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure China Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Japan Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Korea Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure India Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Southeast Asia Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Asia-Pacific Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Brazil Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Argentina Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Columbia Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of South America Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Saudi Arabia Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure United Arab Emirates Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Egypt Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Nigeria Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure South Africa Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Turkey Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Middle East and Africa Biodefense Revenue (Million USD) and Growth Rate (2017-2025)

Table Global Biodefense Revenue and Revenue Share by Product (2017-2018)

Figure Global Radiation/ Nuclear Defense Revenue and Growth Rate (2017-2018)

Figure Global Anthrax Revenue and Growth Rate (2017-2018)

Figure Global Botulism Revenue and Growth Rate (2017-2018)

Figure Global Smallpox Revenue and Growth Rate (2017-2018)

Figure Global Other Products Revenue and Growth Rate (2017-2018)

Table Global Biodefense Revenue by Regions (2017-2018)

Figure North America Biodefense Growth Rate (2017-2018)

Figure North America Biodefense Revenue and Growth Rate (2017-2018)

Figure North America Biodefense by Countries (2017-2018)

Figure North America Biodefense Revenue (Million USD) by Countries (2017-2018)

Figure United States Biodefense Growth Rate (2017-2018)

Figure United States Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Canada Biodefense Growth Rate (2017-2018)

Figure Canada Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Mexico Biodefense Growth Rate (2017-2018)

Figure Mexico Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Europe Biodefense Growth Rate (2017-2018)

Figure Europe Biodefense Revenue and Growth Rate (2017-2018)

Figure Europe Biodefense by Countries (2017-2018)

Figure Europe Biodefense Revenue (Million USD) by Countries (2017-2018)

Figure Germany Biodefense Growth Rate (2017-2018)

Figure Germany Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure France Biodefense Growth Rate (2017-2018)

Figure France Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure UK Biodefense Growth Rate (2017-2018)

Figure UK Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Russia Biodefense Growth Rate (2017-2018)

Figure Russia Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Italy Biodefense Growth Rate (2017-2018)

Figure Italy Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Europe Biodefense Growth Rate (2017-2018)

Figure Rest of Europe Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Asia-Pacific Biodefense Growth Rate (2017-2018)

Figure Asia-Pacific Biodefense Revenue and Growth Rate (2017-2018)

Figure Asia-Pacific Biodefense by Countries (2017-2018)

Figure Asia-Pacific Biodefense Revenue (Million USD) by Countries (2017-2018)

Figure China Biodefense Growth Rate (2017-2018)

Figure China Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Japan Biodefense Growth Rate (2017-2018)

Figure Japan Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Korea Biodefense Growth Rate (2017-2018)

Figure Korea Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure India Biodefense Growth Rate (2017-2018)

Figure India Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Southeast Asia Biodefense Growth Rate (2017-2018)

Figure Southeast Asia Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Biodefense Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South America Biodefense Growth Rate (2017-2018)

Figure South America Biodefense Revenue and Growth Rate (2017-2018)

Figure South America Biodefense by Countries (2017-2018)

Figure South America Biodefense Revenue (Million USD) by Countries (2017-2018)

Figure Brazil Biodefense Growth Rate (2017-2018)

Figure Brazil Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Argentina Biodefense Growth Rate (2017-2018)

Figure Argentina Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Columbia Biodefense Growth Rate (2017-2018)

Figure Columbia Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of South America Biodefense Growth Rate (2017-2018)

Figure Rest of South America Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Middle East and Africa Biodefense Growth Rate (2017-2018)

Figure Middle East and Africa Biodefense Revenue and Growth Rate (2017-2018)

Figure Middle East and Africa Biodefense by Countries (2017-2018)

Figure Middle East and Africa Biodefense Revenue (Million USD) by Countries (2017-2018)

Figure Saudi Arabia Biodefense Growth Rate (2017-2018)

Figure Saudi Arabia Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure United Arab Emirates Biodefense Growth Rate (2017-2018)

Figure United Arab Emirates Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Egypt Biodefense Growth Rate (2017-2018)

Figure Egypt Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Nigeria Biodefense Growth Rate (2017-2018)

Figure Nigeria Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South Africa Biodefense Growth Rate (2017-2018)

Figure South Africa Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Turkey Biodefense Growth Rate (2017-2018)

Figure Turkey Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Biodefense Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Biodefense Revenue (Millions USD) and Growth Rate (2017-2018)

Table Alnylam Pharmaceuticals Inc. Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Ichor Medical Systems Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Xoma Corporation Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Nanotherapeutics Inc. Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table PharmAthene Inc. Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Achaogen Inc. Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Emergent BioSolutions Inc. Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Bavarian Nordic Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Dynavax Technologies Corporation Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Cleveland BioLabs Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table SIGA Technologies Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table DynPort Vaccine Company LLC Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Elusys Therapeutics Inc. Biodefense Price, Revenue, Gross Margin and Market Share (2017-2017)

Figure Global Biodefense Market Share by Manufacturer

Figure Global Biodefense Revenue and Market Share by Manufacturer

Table Global Biodefense Price by Region (2017-2017)

Figure Top 5 Biodefense Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Biodefense Revenue (Millions USD) and Growth Rate (2018-2025)

Table Biodefense Market Forecast by Regions (2018-2025)

Figure North America Biodefense Market Forecast (2018-2025)

Figure United States Biodefense Market Forecast (2018-2025)

Figure Canada Biodefense Market Forecast (2018-2025)

Figure Mexico Biodefense Market Forecast (2018-2025)

Figure Europe Biodefense Market Forecast (2018-2025)

Figure Germany Biodefense Market Forecast (2018-2025)

Figure France Biodefense Market Forecast (2018-2025)

Figure UK Biodefense Market Forecast (2018-2025)

Figure Russia Biodefense Market Forecast (2018-2025)

Figure Italy Biodefense Market Forecast (2018-2025)

Figure Rest of Europe Biodefense Market Forecast (2018-2025)

Figure Asia-Pacific Biodefense Market Forecast (2018-2025)

Figure China Biodefense Market Forecast (2018-2025)

Figure Japan Biodefense Market Forecast (2018-2025)

Figure Korea Biodefense Market Forecast (2018-2025)

Figure India Biodefense Market Forecast (2018-2025)

Figure Southeast Asia Biodefense Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Biodefense Market Forecast (2018-2025)

Figure South America Biodefense Market Forecast (2018-2025)

Figure Brazil Biodefense Market Forecast (2018-2025)

Figure Argentina Biodefense Market Forecast (2018-2025)

Figure Columbia Biodefense Market Forecast (2018-2025)

Figure Rest of South America Biodefense Market Forecast (2018-2025)

Figure Middle East and Africa Biodefense Market Forecast (2018-2025)

Figure Saudi Arabia Biodefense Market Forecast (2018-2025)

Figure United Arab Emirates Biodefense Market Forecast (2018-2025)

Figure Egypt Biodefense Market Forecast (2018-2025)

Figure Nigeria Biodefense Market Forecast (2018-2025)

Figure South Africa Biodefense Market Forecast (2018-2025)

Figure Turkey Biodefense Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Biodefense Market Forecast (2018-2025)

Figure Global Biodefense Forecast by Product (2018-2025)

Figure Global Biodefense Market Share Forecast by Product (2018-2025)

Figure Global Biodefense Forecast by Product (2018-2025)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

Number of patients for particular device or medical procedure and
Repeated use of particular device depending on health and condition of patient

Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample

Requirement/Comment